Cargando…
Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett’s Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens
Barrett’s esophagus (BE) is an acquired pre-malignant condition that results from chronic gastroesophageal reflux. The malignant transformation occurred in 0.5% of patients/year and was independent of medical and endoscopic conservative treatments. Fatty acid synthase (FAS) is a multifunctional enzy...
Autores principales: | Crispino, Pietro, Ciarambino, Tiziana, Giordano, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296950/ https://www.ncbi.nlm.nih.gov/pubmed/37367048 http://dx.doi.org/10.3390/cimb45060299 |
Ejemplares similares
-
Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus
por: Volkweis, Bernardo Silveira, et al.
Publicado: (2012) -
Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett’s esophagus: a matched case–control study
por: Helminen, Olli, et al.
Publicado: (2022) -
Tenascin-C and fibronectin in normal esophageal mucosa, Barrett’s esophagus, dysplasia and adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2017) -
MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus
por: Sreedharan, Loveena, et al.
Publicado: (2017) -
Chemoprevention in Barrett’s esophagus and esophageal
adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021)